All Articles

Case Report 
RET-mutated non-small cell lung cancer treated with pralsetinib: a case series
Alessandro Galletti, Marco Russano, Fabrizio Citarella, Giuseppina Di Fazio, Valentina Santo, Leonardo Brunetti, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
20  
Case Report 
Ineffective target therapy in non-small cell lung cancer harboring BRAF G466R mutation: a case report and biological rationale
Fabrizio Citarella, Marco Russano, Giuseppe Perrone, Giuseppina-Rita Di Fazio, Raffaele Giusti, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
19  
Case Report 
KRAS G12V mutation as an acquired resistance mechanism after treatment with dabrafenib and trametinib in non-small cell lung cancer harbouring the BRAF V600E mutation: a case report
Hajime Oi, Kiyotaka Yoh, Shingo Matsumoto, Hiroki Izumi, Yuji Shibata, Tetsuya Sakai, Kaname Nosaki, Yoshitaka Zenke, Koichi Goto
Precision Cancer Medicine  
2022;
5:
18  
Review Article 
Current evidence of BRCA mutations in genitourinary and gynecologic tumors: a scoping review
Alain Chebly, Tony Yammine, Elie Rassy, Stergios Boussios, Michele Moschetta, Chantal Farra
Precision Cancer Medicine  
2022;
5:
17  
Review Article 
The role of digital and integrative pathology for the detection of translocations: a narrative review
Carlo Beretta, Stefano Ceola, Fabio Pagni, Vincenzo L’Imperio
Precision Cancer Medicine  
2022;
5:
16  
Review Article 
Drug-related toxicity in breast cancer patients: a new path towards tailored treatment?—a narrative review
Eleonora Lai, Mara Persano, Marco Dubois, Dario Spanu, Clelia Donisi, Marta Pozzari, Giulia Deias, Giorgio Saba, Marco Migliari, Nicole Liscia, Mariele Dessì, Mario Scartozzi, Francesco Atzori
Precision Cancer Medicine  
2022;
5:
15  
Review Article 
The past, present, and future of non-metastatic castration-resistant prostate cancer (nmCRPC): a narrative review
Natalia Vidal, Juan Gómez Rivas, Laura Fernández, Jesús Moreno, Javier Puente
Precision Cancer Medicine  
2022;
5:
14  
Review Article 
A narrative review of the management of BRAF non-V600E mutated metastatic non-small cell lung cancer
Inas Abuali, Chung-Shien Lee, Nagashree Seetharamu
Precision Cancer Medicine  
2022;
5:
13  
Original Article 
Prospective and single-blinded evaluation of the multi-cancer Carcimun-test
Andreas Salat, Wieland Voigt, Berthold von und zu Zwerger
Precision Cancer Medicine  
2022;
5:
12  
Editorial 
From icing to slicing the cake: the new hope of precision medicine for lung cancer
Giuseppe L. Banna, Alfredo Addeo
Precision Cancer Medicine  
2022;
5:
11  
Case Report 
Efficacy of pembrolizumab in lung adenocarcinoma harboring non-V600E BRAF mutation: a case report
Giuseppina-Rita Di Fazio, Fabrizio Citarella, Emanuela Dell’Aquila, Marco Russano, Alessandro Galletti, Valentina Santo, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
10  
Case Report 
Uncommon EGFR mutations: state-of-the-art and case reports
Francesca Simionato, Lorenzo Calvetti
Precision Cancer Medicine  
2022;
5:
9  
Case Report 
ALK non-small cell lung cancer sequence of treatment: a case report
Alonso García Miriam, Sánchez Gastaldo Amparo, Bernabé Caro Reyes, Benedetti Pedroza Johana Cristina, Carrasco García Irene
Precision Cancer Medicine  
2022;
5:
8  
Case Report 
Primary lung secretory carcinoma: a case report
Huihua Li, Darya Buehler, Jefree J. Schulte
Precision Cancer Medicine  
2022;
5:
7  
Review Article 
New driver alterations in non-small cell lung cancer: a narrative review
Marco Filetti, Alessandro Rossi, Beatrice Taurelli Salimbeni, Marta Piras, Evelina Rogges, Arianna Di Napoli, Paolo Marchetti, Raffaele Giusti
Precision Cancer Medicine  
2022;
5:
5  
Review Article 
Mechanisms of resistance after crizotinib or second-generation ALK therapy in advanced non-small cell lung cancer
Jordi Remon, Laura Esteller, Lizza E. L. Hendriks
Precision Cancer Medicine  
2022;
5:
4  
Review Article 
Role of radiation therapy in triple negative breast cancer: current state and future directions—a narrative review
Fares Azoury, Shagun Misra, Aisling Barry, Joelle Helou
Precision Cancer Medicine  
2022;
5:
3  
Original Article 
Outcomes of head and neck angiosarcoma with different treatment modalities: a 20-year single institutional experience
Yen Sin Koh, Jason Yongsheng Chan, Wen Shen Looi, Mohamad Farid, N Gopalakrishna Iyer, Ci-An Gerald Tay, Kiattisa Sommat, Ru Xin Wong
Precision Cancer Medicine  
2022;
5:
2  
Editorial 
ALK and ROS-1 NSCLC patients treatment approach based on genomic profile by liquid biopsy
Ernest Nadal, Laura Mezquita, Jesús Corral
Precision Cancer Medicine  
2022;
5:
1  
Case Report 
Partial hippocampal sparing whole brain radiotherapy in a patient with bilateral malignant melanoma metastases to the hippocampus: a case report
Michael J. McKay, Hassan Shoushtari Zadeh, Carolyn Sanderson, Thomas A. McKay, Aaron Chindewere
Precision Cancer Medicine  
2021;
4:
39  
Review Article 
A narrative review of genetic factors affecting fluoropyrimidine toxicity
William H. Gmeiner
Precision Cancer Medicine  
2021;
4:
38  
Review Article 
Empowering childhood cancer survivors through integrated, individualized health insurance education
Brittany C. Kimball, Matthew R. Kudek, Daniel Van Ly, Sarah Eagle, Vanessa Hausman, Eleanor Plaunt, Hee Yun Lee, Karim Thomas Sadak
Precision Cancer Medicine  
2021;
4:
37  
Review Article 
Wielding a double-edged sword in head and neck cancers—diagnosis, risk factors and mitigation strategies of radiation-induced head and neck sarcomas: a narrative review
Tabitha Y. Chan, Venkatesh Alagappan, Balamurugan Vellayappan
Precision Cancer Medicine  
2021;
4:
36  
Review Article 
Metabolic reprogramming and cancer precision medicine: a narrative review
Hong Zhang, Shuang Tang
Precision Cancer Medicine  
2021;
4:
35  
Review Article 
Precision cancer medicine in China: the Fudan University Shanghai Cancer Center experience
Lei-Jie Dai, Ding Ma, Zhi-Ming Shao
Precision Cancer Medicine  
2021;
4:
34  
Review Article 
A narrative review of microRNA therapeutics: understanding the future of microRNA research
Linhui Liang, Xianghuo He
Precision Cancer Medicine  
2021;
4:
33  
Review Article 
FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology
Dan Li, Rebecca Kusko, Baitang Ning, Weida Tong, Donald J. Johann Jr, Joshua Xu
Precision Cancer Medicine  
2021;
4:
32  
Original Article 
Comparison of cancer incidence and mortality between China and the United States
Zezhou Wang, Changming Zhou, Xiaoshuang Feng, Miao Mo, Jie Shen, Ying Zheng
Precision Cancer Medicine  
2021;
4:
31  
Case Report 
Massive hyper-progression during anti-PD-1 immunotherapy in a young patient with metastatic mucinous adenocarcinoma of the right colon: a case report and literature review
Chiara Guarini, Annalisa Todisco, Marco Tucci, Camillo Porta, Francesco Mannavola
Precision Cancer Medicine  
2021;
4:
30  
Review Article 
Women treating lung cancer: a narrative review
Maria Teresa R. Tsukazan, Ana Gelatti, Paula A. Ugalde
Precision Cancer Medicine  
2021;
4:
29  
Review Article 
Next-generation sequencing using liquid biopsy in the care of patients with ALK-rearranged non-small cell lung cancer: a focus on lorlatinib
Juan B. Blaquier, Andrés F. Cardona, Alessandro Russo, Christian Rolfo, Gonzalo Recondo
Precision Cancer Medicine  
2021;
4:
28  
Review Article 
Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review
Alicia A. Zolondick, Giovanni Gaudino, Jiaming Xue, Harvey I. Pass, Michele Carbone, Haining Yang
Precision Cancer Medicine  
2021;
4:
27  
Review Article 
Sex-based heterogeneity in non-small cell lung cancer (NSCLC) and response to immune checkpoint inhibitors (ICIs): a narrative review
Stefano Frega, Alessandra Ferro, Laura Bonanno, Valentina Guarneri, PierFranco Conte, Giulia Pasello
Precision Cancer Medicine  
2021;
4:
26  
Review Article 
ROS1 non-small cell lung cancer patients treatment approach
Laura Moliner, Edurne Arriola
Precision Cancer Medicine  
2021;
4:
25  
Review Article 
A narrative review of biomarkers in advanced triple negative breast cancer
Rania Chehade, Arif A. Awan, Ricardo Fernandes
Precision Cancer Medicine  
2021;
4:
24  
Review Article 
A narrative review of predictive and prognostic biomarkers in skin tumors
Anna M. Stagner, Rosalynn M. Nazarian
Precision Cancer Medicine  
2021;
4:
22  
Editorial Commentary 
PARP inhibitors beyond BRCA-mutated cancers: precision medicine at the crossroads
Bartłomiej Tomasik, Michał Bieńkowski, Jacek Jassem
Precision Cancer Medicine  
2021;
4:
19  
Editorial Commentary 
Lung cancer screening: think pink!
Monica Casiraghi, Lorenzo Spaggiari
Precision Cancer Medicine  
2021;
4:
18  
Case Report 
Effectiveness of pemetrexed-based chemotherapy and radiation therapy in RET-rearranged lung adenocarcinoma: a mono-institutional case series
Fabrizio Citarella, Marco Russano, Alessandro Galletti, Giuseppina-Rita Di Fazio, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2021;
4:
17  
Review Article 
ROS-1 NSCLC therapy resistance mechanism
Miguel García-Pardo, Antonio Calles
Precision Cancer Medicine  
2021;
4:
16  
Review Article 
Monitoring therapeutic response and resistance with liquid biopsy
Virginia Calvo, Atocha Romero, Mariano Provencio
Precision Cancer Medicine  
2021;
4:
15  
Review Article 
Non-small cell lung cancer molecular characterization of advanced disease with focus on sex differences: a narrative review
Rossella Bruno, Greta Alì, Anello Marcello Poma, Gabriella Fontanini
Precision Cancer Medicine  
2021;
4:
14  
Review Article 
A narrative review of chemotherapy in advanced triple negative breast cancer
Maria L. Romero Lagunes, Rossanna C. Pezo
Precision Cancer Medicine  
2021;
4:
13  
Review Article 
Triple negative breast cancer: emerging light on the horizon—a narrative review
Umangjot K. Bharaj, Ana E. Lohmann, Phillip S. Blanchette
Precision Cancer Medicine  
2021;
4:
12  
Original Article 
The use of stereotactic body radiotherapy in pulmonary carcinoid tumors: a case series
Katharine Thomas, Chris Smith, Andrew Marsala, John Philip Boudreaux, Ramcharan Thiagarajan, Robert A. Ramirez
Precision Cancer Medicine  
2021;
4:
11